ConductScience.org, home

Paper20008650

Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.

Morris JC and 8 others. Arch Neurol, 2009. Cited by 364 papers, by iCite.

Cite this record

ConductScience Library. Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease. Papers, record 20008650. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/20008650

Download JSON
Sources
11 sources
Release
papers-2026-11-12-0.1.0

Paper

PubMed's record of the paper, with iCite's citation figures. No abstract is shown.

Title
Pittsburgh compound B imaging and prediction of progression from cognitive normality to symptomatic Alzheimer disease.
PubMed
Journal
Arch Neurol
PubMed
Year
2009
PubMed
Publication types
Comparative Study, Journal Article, Research Support, N.I.H., Extramural, Research Support, Non-U.S. Gov't
PubMed
Citations, by iCite
364
iCite
Relative citation ratio, by iCite
9.96
iCite
Revised in PubMed
2025-05-29
PubMed

Authors9

The authors in the order PubMed's record lists them, with the ORCID iDs it states.

OrderAuthorForenameKindORCID iD
1Morris JCJohn C
2Roe CMCatherine M
3Grant EAElizabeth A
4Head DDenise
5Storandt MMartha
6Goate AMAlison M
7Fagan AMAnne M
8Holtzman DMDavid M
9Mintun MAMark A

Source PubMed

Download CSV of authors

Topics18

NLM's MeSH indexing of the paper, its major topics first.

MeSH termMajor
Alzheimer DiseaseMajor topic
Aniline CompoundsMajor topic
Carbon RadioisotopesMajor topic
CognitionMajor topic
Cognition DisordersMajor topic
ThiazolesMajor topic
Aged
Aged, 80 and over
Cohort Studies
Disease Progression
Female
Follow-Up Studies
Humans
Longitudinal Studies
Male
Middle Aged
Positron-Emission Tomography
Predictive Value of Tests

Source PubMed

Download CSV of topics

Grants9

Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.

Grant, as the record writes itAgencyCountryNIH projectStated bySource
P01AG026276NIA NIH HHSUnited StatesP01AG026276PubMed and NIHNIH RePORTER
P01 AG026276NIA NIH HHSUnited StatesP01AG026276PubMed and NIHNIH RePORTER
UL1 RR024992NCRR NIH HHSUnited StatesUL1RR024992PubMed and NIHNIH RePORTER
P01AG03991NIA NIH HHSUnited StatesP01AG003991PubMed and NIHNIH RePORTER
1UL1RR024992NCRR NIH HHSUnited StatesUL1RR024992PubMed and NIHNIH RePORTER
UL1 TR000448NCATS NIH HHSUnited StatesUL1TR000448PubMed and NIHNIH RePORTER
P50AG05681NIA NIH HHSUnited StatesP50AG005681PubMed and NIHNIH RePORTER
P01 AG003991NIA NIH HHSUnited StatesP01AG003991PubMed and NIHNIH RePORTER
P50 AG005681NIA NIH HHSUnited StatesP50AG005681PubMed and NIHNIH RePORTER

Download CSV of grants

References53

The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.

OrderPMIDTitleJournalYearIn PapersSource
119523877
Prevalence and prognostic value of CSF markers of Alzheimer's disease pathology in patients with subjective cognitive impairment or mild cognitive impairment in the DESCRIPA study: a prospective cohort study.
Lancet Neurol2009https://conductscience.org/library/papers/19523877PubMed
214676043Cerebrospinal fluid tau and beta-amyloid: how well do these biomarkers reflect autopsy-confirmed dementia diagnoses?Arch Neurol2003https://conductscience.org/library/papers/14676043PubMed
316894109Longitudinal course and neuropathologic outcomes in original vs revised MCI and in pre-MCI.Neurology2006https://conductscience.org/library/papers/16894109PubMed
420186853APOE predicts amyloid-beta but not tau Alzheimer pathology in cognitively normal aging.Ann Neurol2010https://conductscience.org/library/papers/20186853PubMed
519296504Cerebrospinal fluid biomarker signature in Alzheimer's disease neuroimaging initiative subjects.Ann Neurol2009https://conductscience.org/library/papers/19296504PubMed
68784228Distribution volume ratios without blood sampling from graphical analysis of PET data.J Cereb Blood Flow Metab1996https://conductscience.org/library/papers/8784228PubMed
717499392PET imaging of amyloid deposition in patients with mild cognitive impairment.Neurobiol Aging2008https://conductscience.org/library/papers/17499392PubMed
817502554Imaging beta-amyloid burden in aging and dementia.Neurology2007https://conductscience.org/library/papers/17502554PubMed
914656067Neuropathology of cognitively normal elderly.J Neuropathol Exp Neurol2003https://conductscience.org/library/papers/14656067PubMed
1020008664Absence of Pittsburgh compound B detection of cerebral amyloid beta in a patient with clinical, cognitive, and cerebrospinal fluid markers of Alzheimer disease: a case report.Arch Neurol2009https://conductscience.org/library/papers/20008664PubMed
118232972The Clinical Dementia Rating (CDR): current version and scoring rules.Neurology1993https://conductscience.org/library/papers/8232972PubMed
1216488378Association between CSF biomarkers and incipient Alzheimer's disease in patients with mild cognitive impairment: a follow-up study.Lancet Neurol2006https://conductscience.org/library/papers/16488378PubMed
1310072051Tangles and plaques in nondemented aging and "preclinical" Alzheimer's disease.Ann Neurol1999https://conductscience.org/library/papers/10072051PubMed
1419001171Frequent amyloid deposition without significant cognitive impairment among the elderly.Arch Neurol2008https://conductscience.org/library/papers/19001171PubMed
151202204"Mini-mental state". A practical method for grading the cognitive state of patients for the clinician.J Psychiatr Res1975https://conductscience.org/library/papers/1202204PubMed
1614872024Higher atrophy rate of entorhinal cortex than hippocampus in AD.Neurology2004https://conductscience.org/library/papers/14872024PubMed
1719376612Neuropathology of nondemented aging: presumptive evidence for preclinical Alzheimer disease.Neurobiol Aging2009https://conductscience.org/library/papers/19376612PubMed
1819475670Amyloid imaging in mild cognitive impairment subtypes.Ann Neurol2009https://conductscience.org/library/papers/19475670PubMed
1919001165Alzheimer disease and cognitive reserve: variation of education effect with carbon 11-labeled Pittsburgh Compound B uptake.Arch Neurol2008https://conductscience.org/library/papers/19001165PubMed
2020049742Cerebrospinal fluid tau and ptau(181) increase with cortical amyloid deposition in cognitively normal individuals: implications for future clinical trials of Alzheimer's disease.EMBO Mol Med2009https://conductscience.org/library/papers/20049742PubMed

See all 53 referencesDownload CSV of references

Cited by238

The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 364 citations.

PMIDTitleJournalYearIn PapersSource
41217839Uncovering pathology, subjective cognitive complaints, and sex in early Alzheimer's disease.J Alzheimers Dis2026https://conductscience.org/library/papers/41217839PubMed
40525437Pharmacological Characterization of Ruellia tuberosa Ethanolic Extract in a Rodent Model of Cognitive Impairment.Recent Adv Inflamm Allergy Drug Discov2026https://conductscience.org/library/papers/40525437PubMed
40496971Neuropsychological and clinical variables associated with cognitive trajectories in patients with Alzheimer's disease.Front Aging Neurosci2025https://conductscience.org/library/papers/40496971PubMed
40327345Research Participant Interest in Learning Results of Biomarker Tests for Alzheimer Disease.JAMA Netw Open2025https://conductscience.org/library/papers/40327345PubMed
40092368Uncovering atrophy progression pattern and mechanisms in individuals at risk of Alzheimer's disease.Brain Commun2025https://conductscience.org/library/papers/40092368PubMed
38514082Quantitative Brain Amyloid PET.J Nucl Med2024https://conductscience.org/library/papers/38514082PubMed
37991017Mitochondria-sequestered Aβ renders synaptic mitochondria vulnerable in the elderly with a risk of Alzheimer disease.JCI Insight2023https://conductscience.org/library/papers/37991017PubMed
37718818Serotonin Degeneration and Amyloid-β Deposition in Mild Cognitive Impairment: Relationship to Cognitive Deficits.J Alzheimers Dis2023https://conductscience.org/library/papers/37718818PubMed
37544835Neuropsychiatric Symptoms and Alzheimer Disease Biomarkers Independently Predict Progression to Incident Cognitive Impairment.Am J Geriatr Psychiatry2023https://conductscience.org/library/papers/37544835PubMed
37371522A Truncated 14-Amino-Acid Myelin Protein-Zero-Targeting Peptide for Fluorescence-Guided Nerve-Preserving Surgery.Biomolecules2023https://conductscience.org/library/papers/37371522PubMed
37315112Gut microbiome composition may be an indicator of preclinical Alzheimer's disease.Sci Transl Med2023https://conductscience.org/library/papers/37315112PubMed
37213538Safety and efficacy of lecanemab for Alzheimer's disease: a systematic review and meta-analysis of randomized clinical trials.Front Aging Neurosci2023https://conductscience.org/library/papers/37213538PubMed
37202518Detection and treatment of Alzheimer's disease in its preclinical stage.Nat Aging2023https://conductscience.org/library/papers/37202518PubMed
36419201Adverse driving behaviors increase over time as a function of preclinical Alzheimer's disease biomarkers.Alzheimers Dement2023https://conductscience.org/library/papers/36419201PubMed
35978440C5aR1 antagonism alters microglial polarization and mitigates disease progression in a mouse model of Alzheimer's disease.Acta Neuropathol Commun2022https://conductscience.org/library/papers/35978440PubMed
35867858Preclinical Alzheimer's disease biomarkers accurately predict cognitive and neuropathological outcomes.Brain2022https://conductscience.org/library/papers/35867858PubMed
35303111Adverse driving behaviors are associated with sleep apnea severity and age in cognitively normal older adults at risk for Alzheimer's disease.Sleep2022https://conductscience.org/library/papers/35303111PubMed
35233522Regional amyloid correlates of cognitive performance in ageing and mild cognitive impairment.Brain Commun2022https://conductscience.org/library/papers/35233522PubMed
34897083Quantitative Gradient Echo MRI Identifies Dark Matter as a New Imaging Biomarker of Neurodegeneration that Precedes Tisssue Atrophy in Early Alzheimer's Disease.J Alzheimers Dis2022https://conductscience.org/library/papers/34897083PubMed
34617016Amyloid-driven disruption of default mode network connectivity in cognitively healthy individuals.Brain Commun2021https://conductscience.org/library/papers/34617016PubMed

See all 238 cited byDownload CSV of cited by

Genes3

The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.

GeneNCBI Gene IDLinked byIn GenesSource
APOE348PubTator's text mininghttps://conductscience.org/library/genes/348NCBI Gene
APP351PubTator's text mininghttps://conductscience.org/library/genes/351NCBI Gene
MAPT4137PubTator's text mininghttps://conductscience.org/library/genes/4137NCBI Gene

Download CSV of genes

Data dates

The date of each source this release read.

PubMed
2026-11-06
PubMed
iCite
2026-11-05
iCite
PMC's ID file
2026-11-05
PMC's ID file
NIH RePORTER's grant and paper links
2026-11-01
NIH RePORTER's grant and paper links
Trials
2026-11-12
Gene search
2026-11-11
Pipelines
2026-09-18

None in this release

  • Trials
  • Comments and corrections
  • Drugs
  • Data

Sources 11

  • ChEMBL, through Open TargetsCC BY-SA 3.0
  • ClinicalTrials.govNo license stated
  • HGNCCC0
  • iCiteCC BY 4.0
  • NCBI GenePublic domain (US government)
  • NIH RePORTER's grant and paper linksPublic domain
  • Open TargetsCC0 1.0
  • PMC's ID filePublic domain (US government)
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0
Each source's terms
  • ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • ClinicalTrials.govnone stated
  • HGNCCC0: https://www.genenames.org/about/license/
  • iCiteCC BY 4.0
  • NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
  • Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
  • PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
  • PubMedNLM's terms
  • PubTator 3Public domain
  • UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this paper from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/papers/v1/20008650

GET https://conductscience.org/api/papers/v1/20008650/references?page=2